Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrin VLA-5 negative primary plasma cell leukemia

K Ohtake1, T Takeuchi, K Saito

  • 1Second Department of Internal Medicine, Saitama Medical Center, Saitama Medical School, Japan.

Internal Medicine (Tokyo, Japan)
|July 1, 1993
PubMed
Summary

This case study details primary plasma cell leukemia, a rare cancer. Combination chemotherapy effectively reduced leukemic cells and Bence Jones protein, aiding in patient management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional study.

Scandinavian journal of rheumatology·2018
Same author

Independent Factors Contributing to Daytime and Nighttime Asthmatic Cough Refractory to Inhaled Corticosteroids.

Journal of investigational allergology & clinical immunology·2018
Same author

IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma.

Allergy·2016
Same author

Mouth breathing, another risk factor for asthma: the Nagahama Study.

Allergy·2016
Same author

A toll-like receptor 3 single nucleotide polymorphism in Japanese patients with sarcoidosis.

Tissue antigens·2015

Area of Science:

  • Hematology
  • Oncology

Background:

  • Primary plasma cell leukemia (PPCL) is an aggressive hematologic malignancy.
  • Bence Jones proteinuria is a key indicator of plasma cell disorders.

Observation:

  • A patient presented with primary plasma cell leukemia and Bence Jones proteinuria.
  • Leukemic cells showed persistent CD38 antigen expression and VLA-4 but not VLA-5.
  • Bone lesions were limited to the skull; typical plasma cells were rare in hyperleukocytic phase but increased later.

Findings:

  • Combination chemotherapy led to decreased leukemic cells and urinary Bence Jones protein.
  • CD38 antigen expression served as a crucial diagnostic marker throughout the illness.
  • The expression profile of very late antigen-4 (VLA-4) and VLA-5 on leukemic cells was noted.

Related Experiment Videos

Implications:

  • This case highlights effective therapeutic strategies for primary plasma cell leukemia.
  • Understanding cellular markers like CD38 and VLA-4 is vital for diagnosis and monitoring.
  • Further research into VLA-4/VLA-5 roles may reveal new treatment targets.